| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | PLN 44.4M | ROE | 18.73% |
| Net Margin | — | ROIC | 23.00% |
| Debt / Equity | 0.14 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Voxel S.A. provides medical services in Poland, focusing on imaging diagnostics that include reimbursed, commercial, and private patient examinations, as well as teleradiology and clinical and pharmaceutical trials. The company is also involved in the sale of radiopharmaceuticals and the leasing of land. It was incorporated in 2005 and is headquartered in Kraków, Poland.
| Market Cap | — | Trading Days | 3748 |
| 52W High | 180.00 |
| 52W Low | 93.80 |
| % Off High | −30.67% |
| YTD | 4.17% | 1Y | −27.05% |
| 3Y | 160.31% | 5Y | 196.80% |
| 10Y | 921.72% | Since incept. (ann.) | 18.61% |
| Ann. Volatility (1Y) | 36.64% | Ann. Volatility (3Y) | 35.91% |
| Sharpe (1Y) | −0.70 | Sharpe (3Y) | 1.12 |
| Max Drawdown (1Y) | −46.59% | Max Drawdown (3Y) | −46.59% |
| Beta (3Y, vs SPY) | 0.77 |
No same-industry peers in the universe for VOX.WA.
